• The protein landscape of CLL is governed by trisomy 12 and IGHV mutational status.

  • Reduced protein abundance buffering implicates the PI3K-AKT-MTOR pathway in the tumorigenic function of trisomy 12.

Many functional consequences of mutations on tumor phenotypes in chronic lymphocytic leukemia (CLL) are unknown. This may be in part due to a scarcity of information on the proteome of CLL. We profiled the proteome of 117 CLL patient samples with data-independent acquisition mass spectrometry and integrated the results with genomic, transcriptomic, ex vivo drug response, and clinical outcome data. We found trisomy 12, IGHV mutational status, mutated SF3B1, trisomy 19, del(17)(p13), del(11)(q22.3), mutated DDX3X and MED12 to influence protein expression (false discovery rate [FDR] = 5%). Trisomy 12 and IGHV status were the major determinants of protein expression variation in CLL as shown by principal-component analysis (1055 and 542 differentially expressed proteins, FDR = 5%). Gene set enrichment analyses of CLL with trisomy 12 implicated B-cell receptor (BCR)/phosphatidylinositol 3-kinase (PI3K)/AKT signaling as a tumor driver. These findings were supported by analyses of protein abundance buffering and protein complex formation, which identified limited protein abundance buffering and an upregulated protein complex involved in BCR, AKT, MAPK, and PI3K signaling in trisomy 12 CLL. A survey of proteins associated with trisomy 12/IGHV-independent drug response linked STAT2 protein expression with response to kinase inhibitors, including Bruton tyrosine kinase and mitogen-activated protein kinase kinase (MEK) inhibitors. STAT2 was upregulated in unmutated IGHV CLL and trisomy 12 CLL and required for chemokine/cytokine signaling (interferon response). This study highlights the importance of protein abundance data as a nonredundant layer of information in tumor biology and provides a protein expression reference map for CLL.

1.
Zenz
T
,
Mertens
D
,
Küppers
R
,
Döhner
H
,
Stilgenbauer
S
.
From pathogenesis to treatment of chronic lymphocytic leukaemia
.
Nat Rev Cancer.
2010
;
10
(
1
):
37
-
50
.
2.
Puente
XS
,
Pinyol
M
,
Quesada
V
, et al
.
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
.
Nature.
2011
;
475
(
7354
):
101
-
105
.
3.
Landau
DA
,
Tausch
E
,
Taylor-Weiner
AN
, et al
.
Mutations driving CLL and their evolution in progression and relapse
.
Nature.
2015
;
526
(
7574
):
525
-
530
.
4.
Rossi
D
,
Spina
V
,
Bomben
R
, et al
.
Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia
.
Blood.
2013
;
121
(
24
):
4902
-
4905
.
5.
Mosquera Orgueira
A
,
Antelo Rodríguez
B
,
Díaz Arias
JA
,
González Pérez
MS
,
Bello López
JL
.
New recurrent structural aberrations in the genome of chronic lymphocytic leukemia based on exome-sequencing data
.
Front Genet.
2019
;
10
:
854
.
6.
Dietrich
S
,
Oleś
M
,
Lu
J
, et al
.
Drug-perturbation-based stratification of blood cancer
.
J Clin Invest.
2018
;
128
(
1
):
427
-
445
.
7.
Ferreira
PG
,
Jares
P
,
Rico
D
, et al
.
Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia
.
Genome Res.
2014
;
24
(
2
):
212
-
226
.
8.
Lu
J
,
Böttcher
M
,
Walther
T
,
Mougiakakos
D
,
Zenz
T
,
Huber
W
.
Energy metabolism is co-determined by genetic variants in chronic lymphocytic leukemia and influences drug sensitivity
.
Haematologica.
2019
;
104
(
9
):
1830
-
1840
.
9.
Johnston
HE
,
Carter
MJ
,
Larrayoz
M
, et al
.
Proteomics profiling of CLL versus healthy B-cells identifies putative therapeutic targets and a subtype-independent signature of spliceosome dysregulation
.
Mol Cell Proteomics.
2018
;
17
(
4
):
776
-
791
.
10.
Díez
P
,
Lorenzo
S
,
Dégano
RM
, et al
.
Multipronged functional proteomics approaches for global identification of altered cell signalling pathways in B-cell chronic lymphocytic leukaemia
.
Proteomics.
2016
;
16
(
8
):
1193
-
1203
.
11.
Eagle
GL
,
Herbert
JMJ
,
Zhuang
J
, et al
.
Assessing technical and biological variation in SWATH-MS-based proteomic analysis of chronic lymphocytic leukaemia cells
.
Sci Rep.
2021
;
11
(
1
):
2932
.
12.
Eagle
GL
,
Zhuang
J
,
Jenkins
RE
, et al
.
Total proteome analysis identifies migration defects as a major pathogenetic factor in immunoglobulin heavy chain variable region (IGHV)-unmutated chronic lymphocytic leukemia
.
Mol Cell Proteomics.
2015
;
14
(
4
):
933
-
945
.
13.
Amon
S
,
Meier-Abt
F
,
Gillet
LC
, et al
.
Sensitive quantitative proteomics of human hematopoietic stem and progenitor cells by data-independent acquisition mass spectrometry
.
Mol Cell Proteomics.
2019
;
18
(
7
):
1454
-
1467
.
14.
Meier
F
,
Brunner
AD
,
Frank
M
, et al
.
diaPASEF: parallel accumulation-serial fragmentation combined with data-independent acquisition
.
Nat Methods.
2020
;
17
(
12
):
1229
-
1236
.
15.
Bruderer
R
,
Bernhardt
OM
,
Gandhi
T
, et al
.
Extending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen-treated three-dimensional liver microtissues
.
Mol Cell Proteomics.
2015
;
14
(
5
):
1400
-
1410
.
16.
Zhang
X
,
Smits
AH
,
van Tilburg
GB
,
Ovaa
H
,
Huber
W
,
Vermeulen
M
.
Proteome-wide identification of ubiquitin interactions using UbIA-MS
.
Nat Protoc.
2018
;
13
(
3
):
530
-
550
.
17.
Vasaikar
S
,
Huang
C
,
Wang
X
, et al;
Clinical Proteomic Tumor Analysis Consortium
.
Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities
.
Cell.
2019
;
177
(
4
):
1035
-
1049.e19
.
18.
Johnson
ECB
,
Dammer
EB
,
Duong
DM
, et al
.
Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease
.
Mol Neurodegener.
2018
;
13
(
1
):
52
.
19.
Zou
C
,
Zhao
M
,
Yu
J
, et al
.
Difference in the vitreal protein profiles of patients with proliferative diabetic retinopathy with and without intravitreal conbercept injection
.
J Ophthalmol.
2018
;
2018
:
7397610
.
20.
Huber
W
,
von Heydebreck
A
,
Sültmann
H
,
Poustka
A
,
Vingron
M
.
Variance stabilization applied to microarray data calibration and to the quantification of differential expression
.
Bioinformatics.
2002
;
18
(
suppl 1
):
S96
-
S104
.
21.
Karp
NA
,
Huber
W
,
Sadowski
PG
,
Charles
PD
,
Hester
SV
,
Lilley
KS
.
Addressing accuracy and precision issues in iTRAQ quantitation
.
Mol Cell Proteomics.
2010
;
9
(
9
):
1885
-
1897
.
22.
Ahlmann-Eltze
C
,
Anders
S
.
proDA: probabilistic dropout analysis for identifying differentially abundant proteins in label-free mass spectrometry
.
bioRxiv.
2019
.
23.
Ritchie
ME
,
Phipson
B
,
Wu
D
, et al
.
limma powers differential expression analyses for RNA-sequencing and microarray studies
.
Nucleic Acids Res.
2015
;
43
(
7
):
e47
.
24.
Gatto
L
,
Lilley
KS
.
MSnbase-an R/Bioconductor package for isobaric tagged mass spectrometry data visualization, processing and quantitation
.
Bioinformatics.
2012
;
28
(
2
):
288
-
289
.
25.
Wu
D
,
Smyth
GK
.
Camera: a competitive gene set test accounting for inter-gene correlation
.
Nucleic Acids Res.
2012
;
40
(
17
):
e133
.
26.
Subramanian
A
,
Tamayo
P
,
Mootha
VK
, et al
.
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles
.
Proc Natl Acad Sci USA.
2005
;
102
(
43
):
15545
-
15550
.
27.
Grambsch
TMTPM
.
Modeling Survival Data: Extending the Cox Model.
New York
:
Springer
;
2000
.
28.
Johnson
WE
,
Li
C
,
Rabinovic
A
.
Adjusting batch effects in microarray expression data using empirical Bayes methods
.
Biostatistics.
2007
;
8
(
1
):
118
-
127
.
29.
Love
MI
,
Huber
W
,
Anders
S
.
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
.
Genome Biol.
2014
;
15
(
12
):
550
.
30.
Anders
S
,
Reyes
A
,
Huber
W
.
Detecting differential usage of exons from RNA-seq data
.
Genome Res.
2012
;
22
(
10
):
2008
-
2017
.
31.
Blischak
JD
,
Carbonetto
P
,
Stephens
M
.
Creating and sharing reproducible research code the workflowr way
.
F1000 Res.
2019
;
8
:
1749
.
32.
Perez-Riverol
Y
,
Csordas
A
,
Bai
J
, et al
.
The PRIDE database and related tools and resources in 2019: improving support for quantification data
.
Nucleic Acids Res.
2019
;
47
(
D1
):
D442
-
D450
.
33.
Quijano
S
,
López
A
,
Rasillo
A
, et al
.
Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia
.
Cytometry B Clin Cytom.
2008
;
74
(
3
):
139
-
149
.
34.
Austen
B
,
Skowronska
A
,
Baker
C
, et al
.
Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion
.
J Clin Oncol.
2007
;
25
(
34
):
5448
-
5457
.
35.
Sato
Y
,
Kamura
T
,
Shirata
N
, et al
.
Degradation of phosphorylated p53 by viral protein-ECS E3 ligase complex
.
PLoS Pathog.
2009
;
5
(
7
):
e1000530
.
36.
Sellmann
L
,
Gesk
S
,
Walter
C
, et al
.
Trisomy 19 is associated with trisomy 12 and mutated IGHV genes in B-chronic lymphocytic leukaemia
.
Br J Haematol.
2007
;
138
(
2
):
217
-
220
.
37.
Obakan
P
,
Barrero
C
,
Coker-Gurkan
A
,
Arisan
ED
,
Merali
S
,
Palavan-Unsal
N
.
SILAC-based mass spectrometry analysis reveals that epibrassinolide induces apoptosis via activating endoplasmic reticulum stress in prostate cancer cells
.
PLoS One.
2015
;
10
(
9
):
e0135788
.
38.
Shuai
S
,
Suzuki
H
,
Diaz-Navarro
A
, et al
.
The U1 spliceosomal RNA is recurrently mutated in multiple cancers
.
Nature.
2019
;
574
(
7780
):
712
-
716
.
39.
Xu
Q
,
Wang
F
,
Xiang
Y
, et al
.
Maternal BCAS2 protects genomic integrity in mouse early embryonic development
.
Development.
2015
;
142
(
22
):
3943
-
3953
.
40.
Kuo
PC
,
Tsao
YP
,
Chang
HW
, et al
.
Breast cancer amplified sequence 2, a novel negative regulator of the p53 tumor suppressor
.
Cancer Res.
2009
;
69
(
23
):
8877
-
8885
.
41.
Kim
SY
,
Volsky
DJ
.
PAGE: parametric analysis of gene set enrichment
.
BMC Bioinformatics.
2005
;
6
(
1
):
144
.
42.
Ruepp
A
,
Brauner
B
,
Dunger-Kaltenbach
I
, et al
.
CORUM: the comprehensive resource of mammalian protein complexes
.
Nucleic Acids Res.
2008
;
36
(
Database issue
):
D646
-
D650
.
43.
Jassal
B
,
Matthews
L
,
Viteri
G
, et al
.
The reactome pathway knowledgebase
.
Nucleic Acids Res.
2020
;
48
(
D1
):
D498
-
D503
.
44.
Rassenti
LZ
,
Jain
S
,
Keating
MJ
, et al
.
Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia
.
Blood.
2008
;
112
(
5
):
1923
-
1930
.
45.
Cui
X
,
Zhang
L
,
Magli
AR
, et al
.
Cytoplasmic myosin-exposed apoptotic cells appear with caspase-3 activation and enhance CLL cell viability
.
Leukemia.
2016
;
30
(
1
):
74
-
85
.
46.
Shailesh
H
,
Zakaria
ZZ
,
Baiocchi
R
,
Sif
S
.
Protein arginine methyltransferase 5 (PRMT5) dysregulation in cancer
.
Oncotarget.
2018
;
9
(
94
):
36705
-
36718
.
47.
Cheng
L
,
Yuan
B
,
Ying
S
, et al
.
PES1 is a critical component of telomerase assembly and regulates cellular senescence
.
Sci Adv.
2019
;
5
(
5
):
eaav1090
.
48.
Chiang
Y
,
Davis
RG
,
Vishwanatha
JK
.
Altered expression of annexin II in human B-cell lymphoma cell lines
.
Biochim Biophys Acta.
1996
;
1313
(
3
):
295
-
301
.
49.
Dayal
S
,
Sparks
A
,
Jacob
J
,
Allende-Vega
N
,
Lane
DP
,
Saville
MK
.
Suppression of the deubiquitinating enzyme USP5 causes the accumulation of unanchored polyubiquitin and the activation of p53
.
J Biol Chem.
2009
;
284
(
8
):
5030
-
5041
.
50.
Platanitis
E
,
Demiroz
D
,
Schneller
A
, et al
.
A molecular switch from STAT2-IRF9 to ISGF3 underlies interferon-induced gene transcription
.
Nat Commun.
2019
;
10
(
1
):
2921
.
51.
Christian
SL
,
Collier
TW
,
Zu
D
,
Licursi
M
,
Hough
CM
,
Hirasawa
K
.
Activated Ras/MEK inhibits the antiviral response of alpha interferon by reducing STAT2 levels
.
J Virol.
2009
;
83
(
13
):
6717
-
6726
.
52.
Perrot
A
,
Pionneau
C
,
Nadaud
S
, et al
.
A unique proteomic profile on surface IgM ligation in unmutated chronic lymphocytic leukemia
.
Blood.
2011
;
118
(
4
):
e1
-
e15
.
53.
Alsagaby
SA
,
Khanna
S
,
Hart
KW
, et al
.
Proteomics-based strategies to identify proteins relevant to chronic lymphocytic leukemia
.
J Proteome Res.
2014
;
13
(
11
):
5051
-
5062
.
54.
Barnidge
DR
,
Jelinek
DF
,
Muddiman
DC
,
Kay
NE
.
Quantitative protein expression analysis of CLL B cells from mutated and unmutated IgV(H) subgroups using acid-cleavable isotope-coded affinity tag reagents
.
J Proteome Res.
2005
;
4
(
4
):
1310
-
1317
.
55.
Cochran
DA
,
Evans
CA
,
Blinco
D
, et al
.
Proteomic analysis of chronic lymphocytic leukemia subtypes with mutated or unmutated Ig V(H) genes
.
Mol Cell Proteomics.
2003
;
2
(
12
):
1331
-
1341
.
56.
Liu
Y
,
Mi
Y
,
Mueller
T
, et al
.
Multi-omic measurements of heterogeneity in HeLa cells across laboratories
.
Nat Biotechnol.
2019
;
37
(
3
):
314
-
322
.
57.
Zhang
B
,
Wang
J
,
Wang
X
, et al;
NCI CPTAC
.
Proteogenomic characterization of human colon and rectal cancer
.
Nature.
2014
;
513
(
7518
):
382
-
387
.
58.
Liu
Y
,
Beyer
A
,
Aebersold
R
.
On the dependency of cellular protein levels on mRNA abundance
.
Cell.
2016
;
165
(
3
):
535
-
550
.
59.
Dephoure
N
,
Hwang
S
,
O’Sullivan
C
, et al
.
Quantitative proteomic analysis reveals posttranslational responses to aneuploidy in yeast
.
eLife.
2014
;
3
:
e03023
.
60.
Geiger
T
,
Cox
J
,
Mann
M
.
Proteomic changes resulting from gene copy number variations in cancer cells
.
PLoS Genet.
2010
;
6
(
9
):
e1001090
.
61.
Stingele
S
,
Stoehr
G
,
Peplowska
K
,
Cox
J
,
Mann
M
,
Storchova
Z
.
Global analysis of genome, transcriptome and proteome reveals the response to aneuploidy in human cells
.
Mol Syst Biol.
2012
;
8
(
1
):
608
.
62.
Hansmann
L
,
Groeger
S
,
von Wulffen
W
,
Bein
G
,
Hackstein
H
.
Human monocytes represent a competitive source of interferon-alpha in peripheral blood
.
Clin Immunol.
2008
;
127
(
2
):
252
-
264
.
63.
van Attekum
MH
,
Eldering
E
,
Kater
AP
.
Chronic lymphocytic leukemia cells are active participants in microenvironmental cross-talk
.
Haematologica.
2017
;
102
(
9
):
1469
-
1476
.
64.
Panayiotidis
P
,
Ganeshaguru
K
,
Jabbar
SA
,
Hoffbrand
AV
.
Alpha-interferon (alpha-IFN) protects B-chronic lymphocytic leukaemia cells from apoptotic cell death in vitro
.
Br J Haematol.
1994
;
86
(
1
):
169
-
173
.
65.
Jewell
AP
,
Worman
CP
,
Lydyard
PM
,
Yong
KL
,
Giles
FJ
,
Goldstone
AH
.
Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo
.
Br J Haematol.
1994
;
88
(
2
):
268
-
274
.
66.
Meier-Abt
F
,
Mokrab
Y
,
Mizuguchi
K
.
Organic anion transporting polypeptides of the OATP/SLCO superfamily: identification of new members in nonmammalian species, comparative modeling and a potential transport mode
.
J Membr Biol.
2005
;
208
(
3
):
213
-
227
.
You do not currently have access to this content.

Sign in via your Institution